Abstract
Chinese Herbal Medicines (CHM) have been used in disease prevention and treatment for centuries in China. A number of anti-breast cancer agents isolated from CHM recently, showed very interesting structures, although some of the mechanism of action is not quite clear. These unique chemical structures could be an important information resource for new anti-breast cancer drugs’ design and discovery. This review summarizes these findings on anti-breast cancer agents from CHM
Keywords: Breast cancer, Chinese herbal medicine(CHM), herb, natural product
Mini-Reviews in Medicinal Chemistry
Title:Anti-Breast Cancer Agents from Chinese Herbal Medicines
Volume: 13 Issue: 1
Author(s): Lisha You, Rui An, Kun Liang and Xinhong Wang
Affiliation:
Keywords: Breast cancer, Chinese herbal medicine(CHM), herb, natural product
Abstract: Chinese Herbal Medicines (CHM) have been used in disease prevention and treatment for centuries in China. A number of anti-breast cancer agents isolated from CHM recently, showed very interesting structures, although some of the mechanism of action is not quite clear. These unique chemical structures could be an important information resource for new anti-breast cancer drugs’ design and discovery. This review summarizes these findings on anti-breast cancer agents from CHM
Export Options
About this article
Cite this article as:
You Lisha, An Rui, Liang Kun and Wang Xinhong, Anti-Breast Cancer Agents from Chinese Herbal Medicines, Mini-Reviews in Medicinal Chemistry 2013; 13 (1) . https://dx.doi.org/10.2174/1389557511307010101
DOI https://dx.doi.org/10.2174/1389557511307010101 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
MicroRNA-34b Inhibits Pancreatic Cancer Metastasis Through Repressing Smad3
Current Molecular Medicine Nuclear Retinoic Acid Receptor Beta as a Tool in Chemoprevention Trials
Current Medicinal Chemistry The Mast Cell Pathway to Inflammation and Homeostasis: Pharmacolo- gical Insights
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Galvez-Markov Network Transferability Indices: Review of Classic Theory and New Model for Perturbations in Metabolic Reactions
Current Drug Metabolism Synthesis and in vitro Cytotoxicity Studies of Certain Novel Heterocycles Derived from Bis 1, 2, 4-Triazoles and their DNA Damage Studies
Medicinal Chemistry Targeted Intraoperative Radiotherapy Tumour Bed Boost During Breast Conserving Surgery after Neoadjuvant Chemotherapy in HER2 Positive and Triple Negative Breast Cancer
Reviews on Recent Clinical Trials The CXCL12/CXCR4 Axis as a Therapeutic Target in Cancer and HIV-1 Infection
Current Medicinal Chemistry Induced Fit Docking and Automated QSAR Studies Reveal the ER-α Inhibitory Activity of <i>Cannabis sativa</i> in Breast Cancer
Recent Patents on Anti-Cancer Drug Discovery Antiproliferative and Antioxidant Potential of Leaf and Leaf Derived Callus Extracts of Aerva lanata (L.) Juss. Ex Schult. Against Human Breast Cancer (MCF-7) Cell Lines
The Natural Products Journal Protein Secretome Analysis of Evolving and Responding Tumor Ecosystems
Current Proteomics Primary Cilia in Tumor Biology: The Primary Cilium as a Therapeutic Target in Cholangiocarcinoma
Current Drug Targets CBP-dependent Wnt/β-catenin signaling is crucial in regulation of MDR1 transcription
Current Cancer Drug Targets Class II Phosphoinositide 3-Kinases as Potential Novel Drug Targets
Current Signal Transduction Therapy Novel Therapeutics Against Breast Cancer Stem Cells by Targeting Surface Markers and Signaling Pathways
Current Stem Cell Research & Therapy Repositioning of DHFR Inhibitors
Current Topics in Medicinal Chemistry Thrombospondins as Anti-Angiogenic Therapeutic Agents
Current Pharmaceutical Design Inflammatory Bowel Disease and Celiac Disease: Overlaps in the Pathology and Genetics, and their Potential Drug Targets
Endocrine, Metabolic & Immune Disorders - Drug Targets Biomarker Diversity, Validation and Clinical Translation: Tenets for Emergent Personalized Medicine Initiatives
Current Pharmacogenomics and Personalized Medicine Function and Regulation of Let-7 Family microRNAs
MicroRNA Semi-Automatic Synthesis of Distamycin Analogues and their DNA Binding Properties
Letters in Drug Design & Discovery